Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-like Illness in Older Adults

Autor: Patricia Kaaijk, Niels Swaans, Alina M. Nicolaie, Jacob P. Bruin, Renée A. J. van Boxtel, Marit M. A. de Lange, Adam Meijer, Elisabeth A. M. Sanders, Marianne A. van Houten, Nynke Y. Rots, Willem Luytjes, Josine van Beek

Publikováno v: Viruses, Vol 14, Iss 4, p 797 (2022)

Influenza-like illness (ILI) can be caused by a range of respiratory viruses. The present study investigates the contribution of influenza and other respiratory viruses, the occurrence of viral co-infections, and the persistence of the viruses after

Externí odkaz: https://doaj.org/article/1a9de55964f6401b93b486e113edccf8

Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

Autor: Maryam Darvishian, Frederika Dijkstra, Eva van Doorn, Maarten J Bijlsma, Gé A Donker, Marit M A de Lange, Laura M Cadenau, Eelko Hak, Adam Meijer

Publikováno v: PLoS ONE, Vol 12, Iss 1, p e0169528 (2017)

Influenza vaccine effectiveness (IVE) varies over different influenza seasons and virus (sub)types/lineages. To assess the association between IVE and circulating influenza virus (sub)types/lineages, we estimated the overall and (sub)type specific IV

Externí odkaz: https://doaj.org/article/df2c7e646da249a284559097fd79ad92

Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands

Autor: Don Klinkenberg, Marit M A de Lange, Adam Meijer, Lenny Stoeldraijer, Wim van der Hoek, Anne C. Teirlinck, Liselotte van Asten, Carel Harmsen, Susan van den Hof, Jan van de Kassteele, Arianne B van Gageldonk-Lafeber

Publikováno v: Emerging Infectious Diseases, Vol 27, Iss 2, Pp 411-420 (2021)
Emerging Infectious Diseases

Since the 2009 influenza pandemic, the Netherlands has used a weekly death monitoring system to estimate deaths in excess of expectations. We present estimates of excess deaths during the ongoing coronavirus disease (COVID-19) epidemic and 10 previou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::476a970e50ced8d464681aa58dde4019
https://wwwnc.cdc.gov/eid/article/27/2/20-2999_article

Absence of association between 2019‐20 influenza vaccination and COVID‐19: Results of the European I‐MOVE‐COVID‐19 primary care project, March‐August 2020

Autor: Alessandra Falchi, Itziar Casado Buesa, Theresa Enkirch, Ana-Maria Vilcu, Mia Brytting, Adam Meijer, Janneke Hendriksen, Josie Murray, Jesús Castilla, Debbie Sigerson, Diogo F P Marques, Vincent Enouf, Sylvie Behillil, Mariëtte Hooiveld, AnnaSara Carnahan, Iván Martínez-Baz, Marta Valenciano, Esther Kissling, Frederika Dijkstra, Naoma William, Marit M A de Lange

Publikováno v: Influenza and Other Respiratory Viruses
Influenza and Other Respiratory Viruses, 2021, ⟨10.1111/irv.12839⟩
Influenza and Other Respiratory Viruses, Wiley Open Access, 2021, ⟨10.1111/irv.12839⟩

The I‐MOVE‐COVID‐19 network has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no 101003673. Background : Claims of influenza vaccination increasing COVID-19 risk are circulating.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7109fce22213ff2056c96741034d7526
https://hal.sorbonne-universite.fr/hal-03119933

Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands

Autor: Peter M. Schneeberger, Marit M A de Lange, Wim van der Hoek, Cornelia C. H. Wielders, Chantal P. Bleeker-Rovers, Jan Jelrik Oosterheert, Frederika Dijkstra, Pieter T de Boer, Sonja E van Roeden

Publikováno v: Emerging Infectious Diseases, Vol 26, Iss 2, Pp 238-246 (2020)
Emerging Infectious Diseases, 26, 238-246
Emerging Infectious Diseases
Emerging Infectious Diseases, 26, 2, pp. 238-246

In the aftermath of a large Q fever (QF) epidemic in the Netherlands during 2007-2010, new chronic QF (CQF) patients continue to be detected. We developed a health-economic decision model to evaluate the cost-effectiveness of a 1-time screening progr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b1dc5f79e0ee887cacee965cda5271f
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/217323